These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 8728197

  • 1. Is atherosclerosis accelerated by CAPD?
    Kawaguchi Y, Kubo H, Yamamoto H, Nakayama M, Yokoyama K, Shigematsu T, Sakai O.
    Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O, Stenvinkel P, Berglund L, Tranoeus A, Lindholm B.
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P.
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [Abstract] [Full Text] [Related]

  • 6. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M, Webb AT, Reaveley DA, Doherty E, O'Donnell M, Seed M, Brown EA.
    Adv Perit Dial; 1997 Apr; 13():168-73. PubMed ID: 9360675
    [Abstract] [Full Text] [Related]

  • 7. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
    Tanaka S.
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Study on vascular calcification in patients on continuous ambulatory peritoneal dialysis (CAPD): special reference to active vitamin D (VD) treatment].
    Yokoyama K.
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1171-80. PubMed ID: 8264107
    [Abstract] [Full Text] [Related]

  • 10. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Kronenberg F, König P, Neyer U, Auinger M, Pribasnig A, Lang U, Reitinger J, Pinter G, Utermann G, Dieplinger H.
    J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular risk factors in diabetic patients undergoing continuous ambulatory peritoneal dialysis.
    Babazono T, Miyamae M, Tomonaga O, Omori Y.
    Adv Perit Dial; 1996 Jul; 12():120-5. PubMed ID: 8865885
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein (a) levels and clinical correlations in CAPD patients.
    Lye WC, Hughes K, Leong SO, Lee EJ.
    Adv Perit Dial; 1995 Jul; 11():131-3. PubMed ID: 8534686
    [Abstract] [Full Text] [Related]

  • 13. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
    Kagan A, Elimalech E, Lemer Z, Fink A, Bar-Khayim Y.
    Perit Dial Int; 1997 Jul; 17(3):243-9. PubMed ID: 9237284
    [Abstract] [Full Text] [Related]

  • 14. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E, Solski J, Janicka L, Ksaziek A, Janicki K.
    Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225
    [Abstract] [Full Text] [Related]

  • 15. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients.
    Eggertsen G, Heimbürger O, Stenvinkel P, Berglund L.
    Nephrol Dial Transplant; 1997 Jan; 12(1):141-4. PubMed ID: 9027789
    [Abstract] [Full Text] [Related]

  • 16. Elevated lipoprotein(a) and fibrinogen levels [corrected] increase the cardiovascular risk in continuous ambulatory peritoneal dialysis patients.
    Bartens W, Nauck M, Schollmeyer P, Wanner C.
    Perit Dial Int; 1996 Jan; 16(1):27-33. PubMed ID: 8616169
    [Abstract] [Full Text] [Related]

  • 17. Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients.
    Ozdemir FN, Güz G, Sezer S, Arat Z, Turan M, Haberal M.
    Artif Organs; 2001 Jun; 25(6):448-52. PubMed ID: 11453874
    [Abstract] [Full Text] [Related]

  • 18. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ, Elisaf MS, Karabina SA, Bairaktari E, Tselepis AD, Siamopoulos KC.
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [Abstract] [Full Text] [Related]

  • 19. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M.
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [Abstract] [Full Text] [Related]

  • 20. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
    Kim SB, Yang WS, Kang ES, Min WK, Park JS.
    Perit Dial Int; 1997 Feb; 17(3):236-42. PubMed ID: 9237283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.